BP PLC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data BP PLC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	186,606	244,582	303,738	163,526	109,078	164,195	248,891	213,032	194,629	192,549
Research and development	400	391	429	364	332	266	274	298	301	274
Operating income	-430	9,474	19,378	11,706	-21,740	18,082	18,039	27,348	11,297	12,642
Interest expense	1,675	2,074	2,528	3,489	3,115	2,857	2,703	3,840	4,683	5,106
Pre-tax income	-2,295	7,180	16,723	8,154	-24,888	15,227	15,405	23,749	6,782	7,746
Income tax	-2,467	3,712	7,145	3,964	-4,159	6,740	16,762	7,869	5,553	6,451
Net income to minority interests	57	79	195	164	-424	922	1,130	641	848	1,240
Net income	115	3,389	9,383	4,026	-20,305	7,565	-2,487	15,239	381	55
EBITDA	14,075	25,058	34,835	29,486	-6,851	32,887	32,357	43,276	27,919	30,464

Balance sheet

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	23,484	25,586	22,468	22,472	31,111	30,681	29,195	33,030	39,204	36,556
Receivables	20,675	24,849	24,478	24,442	17,948	27,139	34,010	31,123	27,127	26,014
Inventory	17,655	19,011	17,988	20,880	16,873	23,711	28,081	22,819	23,232	22,499
Total current assets	67,813	74,968	71,310	82,059	72,982	92,590	107,688	104,146	102,834	101,786
Property, plant and equipment	129,757	129,471	135,261	132,642	114,836	112,902	106,044	104,719	100,238	98,633
Goodwill	11,194	11,551	12,204	11,868	12,480	12,373	11,960	12,472	14,888	10,300
Intangible assets	18,183	18,355	17,284	15,539	6,093	6,451	10,200	9,991	9,646	8,197
Total assets	263,316	276,515	282,176	295,194	267,654	287,272	288,120	280,294	282,228	278,526
Accounts payable	37,915	44,209	46,265	46,829	36,014	52,611	63,984	61,155	58,411	56,843
Total current liabilities	58,354	64,726	68,237	73,595	59,799	80,287	99,018	86,078	82,241	80,581
Lease liabilities			623	7,655	7,329	6,864	6,447	8,471	9,340	11,739
Total liabilities	166,473	176,111	180,628	194,486	182,086	196,833	205,130	194,801	203,910	204,526
Total debt	58,300	63,230	65,132	67,724	72,664	61,176	46,944	51,954	59,547	57,958
Shareholders' equity	95,286	98,491	99,444	98,412	71,250	75,463	67,553	70,283	59,246	53,052
Minority interests	1,557	1,913	2,104	2,296	14,318	14,976	15,437	15,210	19,072	20,948
Total equity	96,843	100,404	101,548	100,708	85,568	90,439	82,990	85,493	78,318	74,000
Total liabilities and equity	263,316	276,515	282,176	295,194	267,654	287,272	288,120	280,294	282,228	278,526

Cash flow statement

	FY2017	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	172	3,468	9,578	4,190	-20,729	8,487	-1,357	15,880	1,229	1,295
Depreciation and amortization	14,505	15,584	15,457	17,780	14,889	14,805	14,318	15,928	16,622	17,822
Cash from operations	10,691	18,931	22,873	25,770	12,162	23,612	40,932	32,039	27,297	24,493
Cash from investing	-14,753	-14,077	-21,571	-16,974	-7,858	-5,694	-13,713	-14,872	-13,250	-11,504
Debt repaid					-2,000
Share buybacks	0	-343	-355	-1,511	-776	-3,151	-9,996	-7,918	-7,127	-4,486
Dividends paid	-4,718	-6,294	-6,869	-7,142	-6,605	-4,627	-4,659	-5,234	-5,393	-5,611
Cash from financing	1,977	-3,296	-4,079	-8,817	3,956	-18,079	-28,021	-13,359	-7,297	-15,880
Exchange rate effect	-820	544	-330	25	379	-269	-684	27	-511	246
Net change in cash	-2,905	2,102	-3,107	4	8,639	-430	-1,486	3,835	6,239	-2,645
Interest paid	1,137	1,572	1,928	2,870	2,728	2,474	2,208	2,950	2,811	3,538

Key metrics

Worked out from the statements above. Latest values use fiscal 2025. Valuation uses the share price of $44.15 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	6.6%	Operating income / revenue.
EBITDA margin	15.8%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	4.0%	Pre-tax income / revenue.
Net margin	0.0%	Net income / revenue.
Operating cash flow margin	12.7%	Cash from operations / revenue.
Effective tax rate	83.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	0.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	0.0%	Net income / average total assets.
Return on invested capital (ROIC)	13.0%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.1%	Research and development expense / revenue.
D&A / revenue	9.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-1.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-8.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	11.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-11.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	9.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-2.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	-85.6%	Net income vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-10.3%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-15.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	15.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-10.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-7.7%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	-5.7%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-1.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-1.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	0.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.26x	Current assets / current liabilities.
Quick ratio	0.78x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.45x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.09x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	20.8%	Total debt / total assets.
Liabilities / assets	73.4%	Total liabilities / total assets.
Net debt	$21.40B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	0.70x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.48x	Operating income / interest expense.
Working capital	$21.21B	Current assets - current liabilities.
Goodwill and intangibles / assets	6.6%	(Goodwill + intangible assets) / total assets.
Tangible book value	$34.56B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.69x	Revenue / average total assets.
Fixed asset turnover	1.94x	Revenue / average property, plant and equipment.
Receivables turnover	7.25x	Revenue / average receivables.
Days sales outstanding	50 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
Payout ratio	10,202.0%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$115.58B	Share price x shares outstanding.
Enterprise value	$136.98B	Market cap + total debt - cash - short-term investments.
P/E	2,101x	Market cap / net income. Only when net income is positive.
P/S	0.60x	Market cap / revenue.
P/B	2.18x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.34x	Market cap / tangible book value, when positive.
P/OCF	4.72x	Market cap / cash from operations, when positive.
EV/Sales	0.71x	Enterprise value / revenue.
EV/EBIT	10.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	4.50x	Enterprise value / EBITDA, when both are positive.
Earnings yield	0.0%	Net income / market cap (the inverse of P/E).
Dividend yield	4.9%	Dividends paid over the period / market cap.
Shareholder yield	8.7%	(Dividends paid + share buybacks) / market cap.

What was BP PLC's revenue in fiscal 2025?

BP PLC reported revenue of $192.55B for fiscal 2025, 1.1% lower than the year before.

Was BP PLC profitable in fiscal 2025?

Yes. Net income was $55.0M, a net margin of 0%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to BP PLC